LEADER 01997nam  2200481   450 
001 9910715497303321
005 20210316092110.0
035   $a(CKB)5470000002511067
035   $a(OCoLC)1241738941
035   $a(EXLCZ)995470000002511067
100   $a20210316d2021      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aCOVID-19: key insights from GAO's oversight of the federal public health response $etestimony before the Committee on Homeland Security, House of Representatives /$fstatement of A. Nicole Clowers
210  1$a[Washington, D.C.] :$cUnited States Government Accountability Office,$d2021.
215   $a1 online resource (13 pages) $ccolor illustrations
225 1 $aTestimony ;$vGAO-21-396T
300   $a"For release on delivery, expected at 9:30 a.m. ET, Wednesday, February 24, 2021."
320   $aIncludes bibliographical references.
517   $aCOVID-19
606   $aCOVID-19 (Disease)$zUnited States
606   $aCOVID-19 Pandemic, 2020-$zUnited States
606   $aCOVID-19 Pandemic, 2020-$xEconomic aspects$zUnited States
606   $aDisaster relief$xFinance$xLaw and legislation$zUnited States
606   $aPublic health administration$zUnited States
606   $aAdministrative agencies$zUnited States$vRules and practice
615  0$aCOVID-19 (Disease)
615  0$aCOVID-19 Pandemic, 2020-
615  0$aCOVID-19 Pandemic, 2020-$xEconomic aspects
615  0$aDisaster relief$xFinance$xLaw and legislation
615  0$aPublic health administration
615  0$aAdministrative agencies
702   $aClowers$b A. Nicole
712 02$aUnited States.$bCongress.$bHouse.$bCommittee on Homeland Security,
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910715497303321
996   $aCOVID-19: key insights from GAO's oversight of the federal public health response$93535430
997   $aUNINA